18. 脊髄小脳変性症(多系統萎縮症を除く。) Spinocerebellar degeneration Clinical trials / Disease details


臨床試験数 : 71 薬物数 : 101 - (DrugBank : 30) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 65

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04817111
(ClinicalTrials.gov)
April 10, 202110/3/2021NAD+ Precursor Supplementation in Friedreich's AtaxiaA Phase 2a Study of NAD+ Precursor Supplementation in Friedreich's AtaxiaFriedreich AtaxiaDrug: MIB-626Metro International Biotech, LLCChildren's Hospital of PhiladelphiaRecruiting18 Years64 YearsAll10Phase 2United States